Information Provided By:
Fly News Breaks for July 14, 2016
GSK
Jul 14, 2016 | 05:24 EDT
Jefferies analyst Jeffrey Holford upgraded GlaxoSmithKline to Buy with a GBP 2,000 price target. Fears of a dividend cut are overdone and the company's improving yield quality will continue to attract investors, Holford tells investors in a research note.
News For GSK From the Last 2 Days
There are no results for your query GSK